Bayer to Increase Pharmaceutical R&D Spend
Bayer have announced additional details on the future of their pharmaceutical research and development business following the announcement earlier this week that they will be concentrating on their healthcare and crop science businesses going forward. The announcement confirmed Bayer plans to float their material science division on the stock market and focus on life sciences,